Editors
Editor (Adis International Limited, Auckland, New Zealand):
Mr Chris Carswell, MSc Pharm. Adis International Limited, Auckland, New Zealand
Founding Editor: Professor John F.P. Bridges, PhD. Ohio State University, Columbus, OH, USA
Editorial Board:
Associate Professor Olalekan L. Aiyegbusi, PhD. University of Birmingham, Birmingham, UK
Professor Giuseppe Banfi, MD. Vita Salute San Raffaele University, Milan, Italy
Associate Professor Zackary Berger, MD. John Hopkins School of Medicine, Baltimore, MD, USA
Ms Kathleen Beusterien, MPH. Kantar Health, Washington, DC, USA
Dr Marco Boeri, PhD. Open Health, Belfast, UK
Associate Professor Derek S. Brown, PhD. Washington University in St. Louis, St. Louis, MO, USA
Professor Stacy Carter, MPH PhD. University of Wollongong, Wollongong, NSW, Australia
Dr Vanita Chamdal, PhD. Royal Holloway, Surrey, UK
Professor Joanna Coast, PhD. University of Bristol, Bristol, UK
Associate Professor Benjamin M. Craig, PhD. University of South Florida, Tampa, FL, USA
Dr Norah L. Crossnohere, PhD. Ohio State University, Columbus, OH, USA
Dr Gillian R. Currie, PhD. University of Calgary, Calgary, AB, Canada
Dr Elin H. Davies, PhD. Aparito, Wrexham, UK
Professor Richard De Abreu Lourenço, MEc PhD. University of Technology Sydney, Sydney, NSW, Australia
Professor Esther W. de Bekker-Grob, PhD. Erasmus University Rotterdam, Rotterdam, the Netherlands
Dr Karen Facey, BSc PhD. University of Edinburgh, Edinburgh, UK
Dr Simon Fifer, PhD. Community and Patient Preference Research, Sydney, NSW, Australia
Dr Emuella Flood, PhD. AstraZeneca, Gaithersburg, MD, USA
Associate Professor Laura Forrest, BSc MGenCouns PhD. Parkville Familial Cancer Centre; and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
Dr Gisselle Gallego, BPharm PhD. The University of Notre Dame Australia, Sydney, NSW, Australia
Assistant Professor Mihir Gandhi, PhD. Duke-NUS Medical School, Singapore, Singapore
Mr Ari Gnanasakthy, MSc MBA. RTI Health Solutions, Research Triangle Park, NC, USA
Assistant Professor Juan-Marcos Gonzalez Sepulveda, PhD. Duke University, Durham, NC, USA
Associate Professor Karla Gough, PhD. Peter MacCallum Cancer Centre; and The University of Melbourne, Melbourne, Victoria, Australia
Associate Professor Catharina Gerarda Maria Groothuis-Oudshoorn, PhD. University of Twente, Enschede, the Netherlands
Dr Mark Harrison, PhD. University of British Columbia, Vancouver, BC, Canada
Dr Kirstie Haywood, BSc(Hons) PhD. University of Warwick, Coventry, UK
Dr Sebastian Heidenreich, PhD. Evidera Inc, London, UK
Associate Professor Mickael Hiligsmann, PhD. Maastricht University, Maastricht, the Netherlands
Dr Ilene L. Hollin, MPH PhD. Temple University, Philadelphia, PA, USA
Professor Kristen Howard, PhD. University of Sydney, Sydney, NSW, Australia
Professor Maarten J. Ijzerman, PhD. Erasmus University Rotterdam, Rotterdam, the Netherlands
Professor Reed Johnson, PhD. Duke University, Durham, NC, USA
Assistant Professor Hae-Young Kim, PhD. New York University, New York, NY, USA
Associate Professor Sanjeewa Kularatna, BDs MSc MD PhD. Duke-Nus Medical School, Singapore
Dr Bennett Levitan, MD PhD. Janssen Research & Development, Titusville, NJ, USA
Professor Luis Lizán, PhD. Universitat Jaume I, Castellón de la Plana, Spain
Professor Paula K. Lorgelly, PhD. University of Auckland, Auckland, New Zealand
Dr Luis Enrique Loría Rebolledo, PhD. University of Aberdeen, Aberdeen, UK
Associate Professor Nan Luo, PhD. National University of Singapore, Singapore
Dr Carol A. Mansfield, PhD. RTI Health Solutions, Research Triangle Park, NC, USA
Professor Emmanouil Mentzakis, PhD. City University of London, London, UK
Professor Dr. Axel C. Mühlbacher. Hochschule Neubrandenburg, Neubrandenburg, Germany
Dr Carina Oedingen, PhD. Erasmus University Rotterdam, Rotterdam, the Netherlands; and University of Calgary, Calgary, AB, Canada
Dr Jan Ostermann, PhD. University of South Carolina, Columbia, SC, USA
Assistant Professor Stephen W. Pan, PhD. University of Texas at San Antonio, San Antonio, TX, USA
Dr Nathan A. Pearson, PhD. University of Warwick, Coventry, UK
Dr Holly L. Peay, MS PhD. RTI International, Research Triangle Park, NC, USA
Visiting Professor Peter J. Pitts, BA. University of Paris School of Medicine, Paris, France
Professor Fanni Rencz, MD MSc PhD. Corvinus University of Budapest, Budapest, Hungary
Dr Sarah Scott, PhD. National Institute for Health and Care Excellence, Manchester, UK
Dr Patti Shih, PhD. University of Wollongong, Wollongong, NSW, Australia
Professor Sophie Staniszewska, DPhil(Oxon) BSc(Hons). University of Warwick, Coventry, UK
Professor Jamie L. Studts, PhD. University of Colorado School of Medicine, Aurora, CO, USA
Professor Fern Terris-Prestholt, PhD. University of Warwick, Coventry, UK
Dr Thao Thai, PhD. Monash University, Melbourne, VIC, Australia
Dr Stephanie Tierney, MA PhD. University of Oxford, Oxford, UK
Dr Janine Astrid van Til, PhD. University of Twente, Enschede, the Netherlands
Dr Caroline M. Vass, PhD. RTI Health Solutions, Manchester, UK
Dr Jorien Veldwijk, PhD. Erasmus University Rotterdam, Rotterdam, the Netherlands
Dr Janine Verstraete, PhD. University of Cape Town, Cape Town, South Africa
Professor Verity Watson, PhD. University of Aberdeen, Aberdeen, UK
Dr Edward J.D. Webb, PhD. University of Leeds, Leeds, UK
Professor Amanda Wheeler, BSc BPharm PGDip PGCertPH PhD. Griffith University, Brisbane, QLD, Australia
Dr Paul J.A. Wicks, PhD. Sano Genetics, London, UK
Dr Eve Wittenberg, MPP PhD. Harvard TH Chan School of Public Health, Boston, MA, USA
Dr Durhane Wong-Rieger, PhD. Canadian Organization for Rare Disorders, Toronto, ON Canada
Dr Albert W. Wu, MD MPH. John Hopkins Bloomberg School of Public Health, Baltimore, MD, USA